These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6721454)

  • 1. Lack of clinical benefit from naloxone in a dementia day hospital.
    Panella JJ; Blass JP
    Ann Neurol; 1984 Mar; 15(3):308. PubMed ID: 6721454
    [No Abstract]   [Full Text] [Related]  

  • 2. Low- and high-dose naloxone in dementia of the Alzheimer type.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.
    N Engl J Med; 1983 Sep; 309(9):555-6. PubMed ID: 6877328
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone and dementia.
    Stowe C; Gora ML
    Ann Pharmacother; 1993 Apr; 27(4):447-8. PubMed ID: 8477122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Day care of aged patients with Alzheimer's disease and related disorders].
    Lago MJ; Lannut H; Jalce R; Burgaud S; Boiste J
    Soins Gerontol; 2000; (26):15-8. PubMed ID: 11309880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Day hospital].
    Podrabinek N; Laudet J
    Soins Gerontol; 1997 Sep; (9):6-18. PubMed ID: 9416232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of naloxone in neurology].
    Mendel T; Barańska-Gieruszczak M
    Neurol Neurochir Pol; 1988; 22(6):553-7. PubMed ID: 3077436
    [No Abstract]   [Full Text] [Related]  

  • 9. Respite care and dementia services program for central New York.
    Perdue J; Nock CM
    Pride Inst J Long Term Home Health Care; 1990; 9(4):3-9. PubMed ID: 10170699
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cognitive effects of cholinesterase inhibitor treatment in every-day practice.
    Kapaki E; Paraskevas GP
    Curr Med Res Opin; 2005 Jun; 21(6):871-5. PubMed ID: 15969887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Day care in the nursing home for patients with dementia: support in a confused world].
    Baumann F
    Pflege Z; 2004 Aug; 57(8):560-2. PubMed ID: 15446339
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes.
    Burke AD; Tariot PN
    Expert Opin Pharmacother; 2009 Oct; 10(15):2407-14. PubMed ID: 19663744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dementia: what the primary care physician must know about it].
    Wettstein A
    Praxis (Bern 1994); 2001 Oct; 90(40):1725-30. PubMed ID: 11680211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of rispolept in mental disorders in patients with Alzheimer and vascular types of dementia].
    Shamreĭ VK; Kolchev AI; Dobrovol'skaia NV
    Voen Med Zh; 2002 Nov; 323(11):47-51. PubMed ID: 12532483
    [No Abstract]   [Full Text] [Related]  

  • 16. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 18. How do elderly spouse care givers of people with Alzheimer disease experience the disclosure of dementia diagnosis and subsequent care?
    Laakkonen ML; Raivio MM; Eloniemi-Sulkava U; Saarenheimo M; Pietilä M; Tilvis RS; Pitkälä KH
    J Med Ethics; 2008 Jun; 34(6):427-30. PubMed ID: 18511613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.
    Summers WK; Viesselman JO; Marsh GM; Candelora K
    Biol Psychiatry; 1981 Feb; 16(2):145-53. PubMed ID: 7225483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.